Mitchell Shirvan sold $31k of SLXN
CSO and CDO at Silexion Therapeutics Corp. 22,818 shares at an average of $1.36, traded Mar 26, 2026, filed Mar 30, 2026.
Score components
- +15RoleOfficer
- +5Trade size$31k at market
- +10Share of holdings soldSold 45% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -45.6%, 3m -77.8%, 6m -97.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001178913-26-001858, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | SOpen-market sale Ordinary Shares | -22,818 | $1.36 | $31k | 27,889 | Mar 30, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.